NPR reports on new work to find drugs to target the RAS cancer gene.
Researchers also combined the 121 SNPs they found with pharmacy data to develop a risk score to predict when patients would start lipid-lowering treatments.
The aim of the clinic is to educate and answer patients' questions about their health risks and consumer genetic testing they've ordered online.
In PNAS this week: DNA damage associated with e-cigarette exposure, inflammasome inhibition by OLT1177, and more.
As the California Institute for Regenerative Medicine runs out of funds, NPR asks whether states will again fund stem cell research.
The firm licensed two methods that help enrich for rare sequences in a complex background that it plans to use in cell-free DNA and microbiology tests.
New studies suggest low-, intermediate-, and high-methylation subgroups exist in juvenile myelomonocytic leukemia, potentially offering insights into patient outcomes.
Based on genotyping data for tens of thousands of individuals across ancestry groups, investigators identified 47 new and known intraocular pressure-associated loci.
In Science this week: new view of human dispersal out of Africa, and more.
UCSF researchers will use NantHealth's GPS Cancer molecular analysis test in their molecular profiling study of metastatic breast cancer.
China may include regulations protecting genes and embryos in its update of its civil code, Nature News reports.
23andMe and Airbnb have partnered to offer "heritage travel," according to Venture Beat.
In Nature this week: exome sequence analysis of individuals with type 2 diabetes, genomic prediction of maize yield across environments, and more.
NPR reports on efforts to engineer bacteriophages to destroy antibiotic-resistance bacteria.